We observed a similar effect when cerebral amyloid angiopathy (CAA) was quantified, and a reduction of CAA was observed in APP/PS1-STZ mice (*p = 0.022 vs. APP/PS1-Sham) (Fig. 3c). This evidence concerns the gene APP and cerebral amyloid angiopathy.